Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI.

AIM To assess topographical and magnetic resonance imaging (MRI) features in characterizing prostate transitional zone (TZ) nodules. MATERIALS AND METHODS Two radiologists evaluated all TZ nodules visible at multiparametric MRI in 52 consecutive patients who underwent radical prostatectomy. The radiologists assessed topographical (anteroposterior and superior-inferior location, crossing of the sagittal midline) and T2-weighted (shape, presence and distinctness of capsule, distinctness of contours, presence of cysts) features, the apparent diffusion coefficient (ADC), and eight semi-quantitative and quantitative enhancement parameters derived from dynamic contrast-enhanced (DCE) imaging. The nature of the nodules was assessed using prostatectomy specimens. Five statistical methods taking into account multiple testing were used. RESULTS One hundred and thirty-seven nodules (117 benign, 20 malignant) were evaluated. Mean ADC, all topographical, and all T2-weighted features were significant predictors of malignancy according to at least four out of the five statistical methods. Particularly, 20/20 and 18/20 cancers involved the anterior and apical third of the TZ, respectively. None of the enhancement parameters was significantly different between cancers and benign nodules. By assessing the presence of cysts, the nodules' capsule, and their anteroposterior and superior-inferior location, 111/117 benign nodules were correctly diagnosed, without misclassifying any cancer. CONCLUSION Topographical, T2-weighted, and diffusion-weighted features can be used to characterize TZ nodules. DCE imaging does not seem to provide additional information.

[1]  Aytekin Oto,et al.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.

[2]  Laura Curiel,et al.  Influence of perfusion on high‐intensity focused ultrasound prostate ablation: A first‐pass MRI study , 2007, Magnetic resonance in medicine.

[3]  Cher Heng Tan,et al.  Diffusion weighted imaging in prostate cancer , 2011, European Radiology.

[4]  J. McNeal,et al.  Patterns of spread of adenocarcinoma in the prostate as related to cancer volume , 2001, The Prostate.

[5]  Valeria Panebianco,et al.  Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. , 2011, European urology.

[6]  Clare Allen,et al.  How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.

[7]  Namkug Kim,et al.  Apparent diffusion coefficient: Prostate cancer versus noncancerous tissue according to anatomical region , 2008, Journal of magnetic resonance imaging : JMRI.

[8]  Carole Lartizien,et al.  Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI , 2012, Physics in medicine and biology.

[9]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.

[10]  Thomas Hambrock,et al.  Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. , 2013, Radiology.

[11]  Aytekin Oto,et al.  Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging. , 2010, World journal of radiology.

[12]  C. Kim,et al.  High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.

[13]  Henkjan J Huisman,et al.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.

[14]  Olivier Rouvière,et al.  Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? , 2007, European Radiology.

[15]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[16]  Olivier Rouvière,et al.  Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging , 2003, European Radiology.

[17]  A. Villers,et al.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.

[18]  M. Colombel,et al.  Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI? , 2012, European Radiology.

[19]  M. Moche,et al.  Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values , 2012, European Radiology.

[20]  A. Villers,et al.  Transition zone and anterior stromal prostate cancers: Zone of origin and intraprostatic patterns of spread at histopathology , 2009, The Prostate.

[21]  J. K. Kim,et al.  Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps. , 2011, AJR. American journal of roentgenology.

[22]  Emilie Niaf,et al.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study , 2013, European Radiology.

[23]  Baris Turkbey,et al.  Imaging localized prostate cancer: current approaches and new developments. , 2009, AJR. American journal of roentgenology.

[24]  Hiroshi Honda,et al.  Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology , 2008, Journal of magnetic resonance imaging : JMRI.

[25]  H. Huisman,et al.  Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.

[26]  Jason A Koutcher,et al.  Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. , 2008, Radiology.

[27]  Evis Sala,et al.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.

[28]  M. Sumura,et al.  Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.

[29]  Y. Yamashita,et al.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation , 2010, European Radiology.

[30]  Clare Allen,et al.  Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.

[31]  Xavier Leroy,et al.  Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings , 2009, European Radiology.

[32]  Yuri Kitamura,et al.  Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. , 2006, AJR. American journal of roentgenology.